799293-85-9 Usage
Description
3-Bromothieno[3,2-c]pyridin-4-amine is a heterocyclic organic compound characterized by the presence of a bromine atom attached to a thieno[3,2-c]pyridine ring, with an amine functional group at the 4-position. 3-bromothieno[3,2-c]pyridin-4-amine exhibits unique electronic and structural properties that make it a valuable building block in the synthesis of various organic materials.
Uses
Used in Organic Synthesis:
3-Bromothieno[3,2-c]pyridin-4-amine is used as a key intermediate in the synthesis of a wide range of organic compounds, including pharmaceuticals, agrochemicals, and advanced materials. Its versatile structure allows for further functionalization and modification, enabling the development of new molecules with tailored properties and applications.
Used in Organic Electroluminescent Devices:
3-Bromothieno[3,2-c]pyridin-4-amine is used as a precursor in the preparation of organic compounds for organic electroluminescent (OLED) devices. These devices are widely used in display technologies, lighting, and other optoelectronic applications due to their high efficiency, low power consumption, and potential for flexible and transparent designs. The incorporation of 3-bromothieno[3,2-c]pyridin-4-amine into the molecular structure of OLED materials can enhance their performance, stability, and color tunability.
Check Digit Verification of cas no
The CAS Registry Mumber 799293-85-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,9,2,9 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 799293-85:
(8*7)+(7*9)+(6*9)+(5*2)+(4*9)+(3*3)+(2*8)+(1*5)=249
249 % 10 = 9
So 799293-85-9 is a valid CAS Registry Number.
799293-85-9Relevant articles and documents
N-(SUBSTITUTED-PHENYL)-SULFONAMIDE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 28-29, (2018/04/11)
The invention relates to N-(substituted-phenyl)-sulfonamide compounds, which are extremely useful as inhibitors of protein kinases (e.g. PERK kinase) and accordingly can be used for the treatment of cell proliferative disorders, such as cancer, or diseases associated with activated unfolded protein response pathways, such as Alzheimer's disease. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds.
Discovery of thienopyridines as Src-family selective Lck inhibitors
Abbott, Lily,Betschmann, Patrick,Burchat, Andrew,Calderwood, David J.,Davis, Heather,Hrnciar, Peter,Hirst, Gavin C.,Li, Biqin,Morytko, Michael,Mullen, Kelly,Yang, Bryant
, p. 1167 - 1171 (2007/10/03)
We describe the identification, SAR, and in vivo pharmacology of a new series of Src-family selective Lck inhibitors. These thienopyridines were designed based on a desire to access the unique residues in the extended hinge region of Lck.
Inhibitors of protein kinases
-
Page/Page column 20, (2010/11/27)
Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed.
